The Second Middle East Lung Cancer Congress is a platform for discussing recent advances in understanding the pathophysiology of lung cancer. It will enhance multidisciplinary collaboration between various specialties involved in the care of lung cancer patients.
Attendees will be able to do the following upon completion of this activity:
Provide a multidisciplinary (MDT) approach to patients with lung cancer that involves the pathologists, pulmonologist, thoracic surgeon as well as medical oncologist; MDT is the new standard of approach and this conference aims at showing the benefit of this approach.
Discuss recent advances in lung cancer therapy for both non-small cell lung cancer and small cell lung cancer.
Better understand recent therapies mechanism of action and toxicities and new treatment modalities such as immunotherapy.
This congress targets medical oncologists, radiation oncologists,
surgeons, radiologists, pathologists, pulmonologists, residents,
fellows, nurses and medical students.